We are live on ! Find out more
Charles Schwab

Charles Schwab Portfolio holdings

AUM $654B
1-Year Est. Return 26.35%
 

Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.

This Fund
S&P 500
This Quarter Est. Return
-13.05%
1 Year Est. Return
+26.35%
3 Year Est. Return
+83.88%
5 Year Est. Return
+111.55%
10 Year Est. Return
+435.01%
AUM
$287B
AUM Growth
-$45.4B
Cap. Flow
+$4.91B
Cap. Flow %
1.71%
Top 10 Hldgs %
16.91%
Holding
3,742
New
162
Increased
2,018
Reduced
1,243
Closed
206

Sector Composition

Rank Sector Weight
1 Technology 19.98%
2 Healthcare 13.1%
3 Financials 12.8%
4 Consumer Discretionary 9.34%
5 Industrials 8.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KOPN icon
3401
Kopin
KOPN
$663M
$46K ﹤0.01%
40,189
-177,174
-82% -$266K
MBRX icon
3402
Moleculin Biotech
MBRX
$7.21M
$46K ﹤0.01%
84
+30
+56% +$17.5K
MNOV icon
3403
MediciNova
MNOV
$66M
$46K ﹤0.01%
17,843
BDTX icon
3404
Black Diamond Therapeutics
BDTX
$98.6M
$45K ﹤0.01%
17,994
-30,293
-63% -$70.4K
STIM icon
3405
Neuronetics
STIM
$137M
$45K ﹤0.01%
13,837
-54,771
-80% -$159K
RVLP
3406
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
$45K ﹤0.01%
32,713
LAB icon
3407
Standard BioTools
LAB
$351M
$44K ﹤0.01%
27,127
-170,026
-86% -$421K
SNCR
3408
DELISTED
Synchronoss Technologies
SNCR
$44K ﹤0.01%
4,207
AGFS
3409
DELISTED
AgroFresh Solutions Inc
AGFS
$44K ﹤0.01%
24,132
-4,259
-15% -$7.57K
DS
3410
DELISTED
Drive Shack Inc.
DS
$44K ﹤0.01%
31,442
-188,302
-86% -$268K
DAKT icon
3411
Daktronics
DAKT
$941M
$43K ﹤0.01%
14,170
-83,745
-86% -$280K
ITI
3412
DELISTED
Iteris, Inc.
ITI
$43K ﹤0.01%
14,737
-95,221
-87% -$265K
ZYNE
3413
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
$43K ﹤0.01%
+37,596
New +$47.9K
ELVT
3414
DELISTED
Elevate Credit, Inc.
ELVT
$43K ﹤0.01%
18,040
GNPX icon
3415
Genprex
GNPX
$3.06M
$42K ﹤0.01%
1
OVID icon
3416
Ovid Therapeutics
OVID
$442M
$42K ﹤0.01%
19,452
PXLW icon
3417
Pixelworks
PXLW
$37.4M
$42K ﹤0.01%
1,830
STXS icon
3418
Stereotaxis
STXS
$133M
$42K ﹤0.01%
22,696
-113,412
-83% -$271K
NAGE
3419
Niagen Bioscience
NAGE
$264M
$42K ﹤0.01%
24,667
-102,969
-81% -$201K
LPCN icon
3420
Lipocine
LPCN
$17.4M
$41K ﹤0.01%
2,941
SUP
3421
DELISTED
Superior Industries International
SUP
$41K ﹤0.01%
10,350
ALPP
3422
DELISTED
Alpine 4 Holdings Inc
ALPP
$41K ﹤0.01%
7,198
NOVN
3423
DELISTED
Novan, Inc. Common Stock
NOVN
$41K ﹤0.01%
+17,180
New +$47.4K
VATE icon
3424
INNOVATE Corp
VATE
$111M
$40K ﹤0.01%
2,312
-10,587
-82% -$290K
NNBR icon
3425
NN Inc
NNBR
$257M
$39K ﹤0.01%
15,065
-93,135
-86% -$258K

Similar funds

Charles Schwab's Q2 2022 Portfolio in Review

As of Q2 2022, Charles Schwab held 3,742 positions worth $287B, down 14% from $333B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Charles Schwab's Q2 2022 filing shows 162 new, 2,018 increased, 1,243 reduced and 206 closed positions. Its largest new stake was iShares 7-10 Year Treasury Bond ETF: 435,453 shares worth $44.5M. The largest sale was State Street SPDR Portfolio Short Term Treasury ETF, an estimated $454M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 21% a quarter earlier, followed by Healthcare and Financials.

  • Charles Schwab's largest Q2 2022 buy was iShares 7-10 Year Treasury Bond ETF: 435,453 shares worth $44.5M.
  • Charles Schwab added most to Cisco in Q2 2022, an estimated $554M increase.
  • Charles Schwab's biggest Q2 2022 reduction was State Street SPDR Portfolio Short Term Treasury ETF, cutting an estimated $454M.
  • Charles Schwab fully exited Cerner Corp in Q2 2022, selling an estimated $140M.
  • Charles Schwab's ten largest holdings make up 17% of its $287B portfolio in Q2 2022.
  • Charles Schwab opened 162 new positions and closed 206 in Q2 2022.
  • Charles Schwab's portfolio value fell 14% quarter-over-quarter to $287B.

Based on Charles Schwab's 13F filing for Q2 2022, filed 15 Aug 2022.